We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Gsk Plc | LSE:GSK | London | Ordinary Share | GB00BN7SWP63 | ORD 31 1/4P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
17.00 | 0.98% | 1,750.50 | 1,750.50 | 1,751.00 | 1,751.50 | 1,736.00 | 1,736.00 | 1,625,706 | 12:49:24 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Pharmaceutical Preparations | 30.33B | 4.93B | 1.1970 | 14.59 | 71.92B |
TIDMGSK
RNS Number : 7167X
GlaxoSmithKline PLC
23 February 2017
GlaxoSmithKline plc (the 'Company')
Transaction notification
1. Details of PDMR/person closely associated with them ('PCA') === =================================================================================== a) Name Mr S Dingemans === =============================== ================================================== b) Position/status Chief Financial Officer === =============================== ================================================== c) Initial notification/ Initial Notification amendment === =============================== ================================================== 2. Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor === =================================================================================== a) Name GlaxoSmithKline plc === =============================== ================================================== b) LEI 5493000HZTVUYLO1D793 === =============================== ================================================== 3. Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transaction(s) has been conducted === =================================================================================== a) Description of Ordinary shares of 25 pence each ('Ordinary the financial Shares') instrument ISIN: GB0009252882 === =============================== ================================================== b) Nature of the The exercise of nil-cost options over transaction Ordinary Shares granted on 12 February 2014 under the Company's 2009 Deferred Annual Bonus Plan - Deferred Bonus and Matching Awards. === =============================== ================================================== c) Price(s) and volume(s) Price(s) Volume(s) === =============================== ================ ============================ GBP0.0000 22,448 (Deferred) === =============================== ================ ============================ GBP0.0000 7,483 (Matching) ================ ============================ , === =============================== ================ ============================ d) Aggregated information === Aggregated volume 29,931 Price GBP0.0000 === =============================== ================================================== e) Date of the transaction 2017-02-22 === =============================== ================================================== f) Place of the transaction n/a === =============================== ================================================== 1. Details of PDMR/person closely associated with them ('PCA') === ===================================================================================== a) Name Mr S Dingemans === =============================== ==================================================== b) Position/status Chief Financial Officer === =============================== ==================================================== c) Initial notification/ Initial Notification amendment === =============================== ==================================================== 2. Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor === ===================================================================================== a) Name GlaxoSmithKline plc === =============================== ==================================================== b) LEI 5493000HZTVUYLO1D793 === =============================== ==================================================== 3. Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transaction(s) has been conducted === ===================================================================================== a) Description of Ordinary shares of 25 pence each ('Ordinary the financial Shares') instrument ISIN: GB0009252882 === =============================== ==================================================== b) Nature of the The sale of Ordinary Shares to meet tax transaction liabilities on nil-cost options over Ordinary Shares exercised on 22 February 2017 under the Company's Deferred Annual Bonus Plan - Deferred Bonus and Matching Awards. === =============================== ==================================================== c) Price(s) and volume(s) Price(s) Volume(s) === =============================== ================== ============================ GBP16.3850 10,763 (Deferred) === =============================== ================== ============================ GBP16.4007 3,589 (Matching) ================== ============================ d) Aggregated information === Aggregated volume 14,352 Price GBP16.3889 === =============================== ==================================================== e) Date of the transaction 2017-02-22 === =============================== ==================================================== f) Place of the transaction London Stock Exchange (XLON) === =============================== ====================================================
This information is provided by RNS
The company news service from the London Stock Exchange
END
DSHZXLFLDLFEBBE
(END) Dow Jones Newswires
February 23, 2017 09:57 ET (14:57 GMT)
1 Year Gsk Chart |
1 Month Gsk Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions